Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Broadvector withdraws IPO on the Australian Stock Exchange

Executive Summary

Broadvector Ltd. (gene therapies for conditions that occur with aging) has filed for its initial public offering on the Australian Stock Exchange. In an open offer, the company hopes to raise A$8.5mm ($8.1mm) by selling 42.5mm new shares at A$0.20 apiece. For every four shares issued, Broadvector will grant one option.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Withdrawn
Deal Type
  • Financing
    • IPO

Related Companies